Literature DB >> 22270043

The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?

F J A Dennissen1, N Kholod, F W van Leeuwen.   

Abstract

A shared hallmark for many neurodegenerative disorders is the accumulation of toxic protein species which is assumed to be the cause for these diseases. Since the ubiquitin proteasome system (UPS) is the most important pathway for selective protein degradation it is likely that it is involved in the aetiology neurodegenerative disorders. Indeed, impairment of the UPS has been reported to occur during neurodegeneration. Although accumulation of toxic protein species (amyloid β) are in turn known to impair the UPS the relationship is not necessarily causal. We provide an overview of the most recent insights in the roles the UPS plays in protein degradation and other processes. Additionally, we discuss the role of the UPS in clearance of the toxic proteins known to accumulate in the hallmarks of neurodegenerative diseases. The present paper will focus on critically reviewing the involvement of the UPS in specific neurodegenerative diseases and will discuss if UPS impairment is a cause, a consequence or both of the disease. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22270043     DOI: 10.1016/j.pneurobio.2012.01.003

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  59 in total

Review 1.  The Role of Proteases in Hippocampal Synaptic Plasticity: Putting Together Small Pieces of a Complex Puzzle.

Authors:  Ivan L Salazar; Margarida V Caldeira; Michele Curcio; Carlos B Duarte
Journal:  Neurochem Res       Date:  2015-11-07       Impact factor: 3.996

2.  Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.

Authors:  Kyoung-in Cho; Hemangi Patil; Eugene Senda; Jessica Wang; Haiqing Yi; Sunny Qiu; Dosuk Yoon; Minzhong Yu; Andrew Orry; Neal S Peachey; Paulo A Ferreira
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

3.  Proteasome regulates the mediators of cytoplasmic polyadenylation signaling during late-phase long-term potentiation.

Authors:  Chenghai Dong; Anirudh Vashisht; Ashok N Hegde
Journal:  Neurosci Lett       Date:  2014-09-28       Impact factor: 3.046

Review 4.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

5.  Regulation of neuronal survival and morphology by the E3 ubiquitin ligase RNF157.

Authors:  A Matz; S-J Lee; N Schwedhelm-Domeyer; D Zanini; A Holubowska; M Kannan; M Farnworth; O Jahn; M C Göpfert; J Stegmüller
Journal:  Cell Death Differ       Date:  2014-10-24       Impact factor: 15.828

6.  UCH-L1 inhibition involved in CREB dephosphorylation in hippocampal slices.

Authors:  Min Xie; Shao-Hui Wang; Zhi-Min Lu; Ying Pan; Qi-Cai Chen; Xiao-Mei Liao
Journal:  J Mol Neurosci       Date:  2013-12-10       Impact factor: 3.444

Review 7.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

8.  Proteasome modulates positive and negative translational regulators in long-term synaptic plasticity.

Authors:  Chenghai Dong; Svitlana V Bach; Kathryn A Haynes; Ashok N Hegde
Journal:  J Neurosci       Date:  2014-02-26       Impact factor: 6.167

Review 9.  Physiological and environmental control of yeast prions.

Authors:  Tatiana A Chernova; Keith D Wilkinson; Yury O Chernoff
Journal:  FEMS Microbiol Rev       Date:  2013-12-04       Impact factor: 16.408

10.  Synthesis of Lithocholic Acid Derivatives as Proteasome Regulators.

Authors:  Zhao Dang; Kathy Jung; Keduo Qian; Kuo-Hsiung Lee; Li Huang; Chin-Ho Chen
Journal:  ACS Med Chem Lett       Date:  2012-08-15       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.